STOCKWATCH
·
Pharmaceuticals
MoU31 Jan 2025, 12:19 am

Shree Ganesh Remedies Limited Signs MOU for Long-Term Strategic Supply with Leading Japanese Company

AI Summary

Shree Ganesh Remedies Limited (SGRL) has announced the execution of a Long-Term Strategic Supply Agreement (SSA) with a leading Japanese company. The agreement, formalised on 30th January 2025, is set for an initial term of three years, with the potential for extension by an additional two years. Under this strategic partnership, SGRL will engage in contract manufacturing for three innovative products, which are poised to make their debut as the first of their kind in India. These products will be developed employing advanced methodologies in Chlorination and Reduction chemistry. The Memorandum of Understanding (MOU) serves as a pivotal starting point for SGRL's strategic contract manufacturing venture, aimed at addressing the demand within the Specialty Chemicals markets.

Key Highlights

  • SGRL signs a Long-Term Strategic Supply Agreement with a leading Japanese company
  • The agreement is set for an initial term of three years with the potential for extension by two years
  • SGRL will engage in contract manufacturing for three innovative products
  • These products will be developed using advanced Chlorination and Reduction chemistry
  • This partnership aims to address the demand within the Specialty Chemicals markets
SGRL
Pharmaceuticals
Shree Ganesh Remedies Ltd

Price Impact